Answering the need for rapid and precise fertility testing solutions.
There is a strong trend in the developed world to delay the decision to have children. This decision is often shifted to the late reproductive years. The delay in having children has increased the incidence of infertility1 and around 17.5% of the adult population (roughly 1 in 6 worldwide) experience infertility issues2. As a result, the use of assisted reproductive technology (ART) by infertile couples is increasing by 5–10% per year.3 Benefits of the AMH assay:
- Rapid and precise assessment of ovarian reserve and fertility status
- Simple integration into routine reproductive endocrinology testing workflow on one platform
- Actionable results from an assay that demonstrates optimal analytical and clinical performance
